In 1990, following the success of the Medicare Inpatient Prospective Payment System (IPPS) based on DRGs, the U.S. Congress required the Centers for Medicare & Medicaid Services (CMS) to develop an outpatient prospective payment system (OPPS). The contract to develop APGs was awarded to Solventum. Throughout the 1990s, six major payers implemented payment methods based on APGs.
In 1999, however, congressional action required the new Medicare method to take more of a fee schedule approach. Payment based on APCs was implemented in August 2000. Because APCs took a fee schedule approach and had a high degree of Medicare specificity, there was demand from other payers and health care organizations for a different approach. In response, Solventum developed the Solventum EAPGs which were first released in 2007 and have since become the industry standard alternative to APCs.
Solventum EAPGs are designed to categorize, in a clinically meaningful way, the resources used to provide different types of care in various outpatient settings. If there is a significant procedure present, such as a laparoscopic cholecystectomy, the visit is a significant procedure visit and related ancillary services are bundled into the significant procedure. If there is no significant procedure, then the algorithm checks for a medical visit indicator. If present, the visit is a medical visit (e.g., for abdominal pain), and related ancillary services are bundled into the medical visit EAPG. If there is neither a significant procedure nor a medical visit indicator, then the visit is an ancillary visit. Services such as lab and imaging are paid individually, with discounting of related services.
These three Solventum EAPG policies provide important incentives for efficiency and cost control:
- Ancillary packaging: Refers to the inclusion of related ancillary services into the Solventum EAPG payment rate for a significant procedure or medical visit. An example would be packaging of routine blood tests.
- Significant and other procedure consolidation: Refers to the collapsing of multiple clinically related procedure Solventum EAPGs into a single Solventum EAPG to determine payment. For example, when a claim includes both Solventum EAPG 3 Level I Skin Incision and Drainage, Debridement, Destruction, Other Related Px and Solventum EAPG 16 Simple Wound Repair and Treatment, then Solventum EAPG 16 is consolidated into Solventum EAPG 3. Solventum EAPG 16 is shown on the claim but with zero payment.
- Discounting: Refers to a reduction in the Solventum EAPG relative weight (and therefore the payment) when two or more procedures are performed during the same visit. An example would be procedure on both the lower leg and the arm.
The clinical logic is maintained by a team of Solventum clinicians, data analysts, programmers and economists. The Solventum proprietary logic is available for licensees to view in an online definition’s manual.
Each year, Solventum calculates and releases a set of statistics for each Solventum EAPG based on our analysis of large national data sets. These statistics include a relative weight for each Solventum EAPG. The relative weight reflects the average resource use for a patient in that Solventum EAPG relative to a subset of common ambulatory services, please note that payers and other users of the Solventum EAPG methodology are responsible for using relative weights appropriate for their populations.
Solventum EAPGs can be rolled up into broader categories. The 648 Solventum EAPGs in version 3.16 (2021) roll up into 13 Solventum EAPG types, such as 2—Significant Procedure and 3—Medical Visit. The Solventum EAPGs also roll up into 61 categories, such as 15—Radiologic Procedures and 62—Diabetes Mellitus.